Indapamida Azevedos

Indapamide, the active ingredient in Indapamida Azevedos, is a thiazide‑like diuretic presented as an unknown strength/unknown form for oral use. It is employed to lower blood pressure and to reduce fluid accumulation in patients with hypertension, heart‑failure‑related edema, or renal‑disease‑related edema.

GNH USA supplies Indapamida Azevedos as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Indapamide acts on the renal tubular system to manage conditions characterized by excess fluid or elevated blood pressure.

Hypertension: helps lower systemic arterial pressure in adult patients. Edema associated with heart failure: promotes fluid loss to relieve congestive symptoms. Edema associated with renal disease: facilitates diuresis to reduce volume overload.

Indapamide may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness or light‑headedness - Headache - Increased frequency of urination - Electrolyte imbalance, especially low potassium - Fatigue or weakness - Nausea or abdominal discomfort

Serious or Rare Side Effects: - Severe dehydration or volume depletion - Allergic reactions such as rash, angioedema, or anaphylaxis - Significant electrolyte disturbances (e.g., severe hypokalemia, hyponatremia) - Decline in renal function or acute kidney injury - Blood dyscrasias such as agranulocytosis or leukopenia

Before initiating therapy, clinicians should consider several safety measures. - Electrolyte monitoring: check serum potassium and sodium regularly. - Renal function assessment: evaluate creatinine clearance prior to use. - Gout risk: use cautiously in patients with a history of gout. - Abrupt discontinuation: avoid sudden stop to prevent rebound hypertension. - Hepatic impairment: dose adjustment may be required. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Indapamide can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Lithium: increased lithium levels may cause toxicity. - Cyclosporine: combined use can heighten risk of nephrotoxicity. - Antidiabetic agents: enhanced hypoglycemic effect may occur.

Moderate Interactions (Monitor Closely): - NSAIDs: may reduce diuretic effectiveness and impair renal function. - Beta‑blockers: additive blood‑pressure‑lowering effect. - Calcium‑channel blockers: potential for enhanced hypotension. - Digoxin: altered serum levels due to electrolyte changes. - Alcohol: may increase dizziness and orthostatic hypotension.